Edit |   |
---|---|
Antigenic Specificity | MSTN, Human (Stamulumab biosimilar) |
Clone | Stamulumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FuncS, IF, Neut, ELISA, FCM, IP, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human MSTN Recombinant Antibody (Stamulumab). Stamulumab (MYO-029) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD). Stamulumab was formulated and tested by Wyeth in Collegeville, Pennsylvania. |
Immunogen | n/a |
Other Names | Anti-MSTN Recombinant Antibody, Research Grade Stamulumab, Anti-Human MSTN Recombinant Antibody(Stamulumab), MYO-029, Antibody Drug Analogues, Monoclonal Antibody, YR1127, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 705287-60-1 |
Catalog # | YR1127 |
Price | please inquire |
Order / More Info | MSTN, Human (Stamulumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |